This is a mystery that has led to numerous studies to investigate the relationship between the two diseases and to discover whether it is true that patients with metabolic syndrome are more prone to developing benign prostatic hyperplasia. The latest research, published in the journal Diabetology & metabolic syndrome In this way, we intend to evaluate the association between both pathologies in men who underwent surgery for benign prostatic hyperplasia.
The study, conducted with 128 men with hyperplasia and 141 without it, sought to identify hormonal and metabolic factors that influence the development of both conditions. Data such as lipid profile, fasting glucose, total and free testosterone, and sex hormone-binding globulin (SHBG) were analyzed, among others.
The research results have shown that the prevalence of metabolic syndrome is higher in patients with benign prostatic hyperplasia (BPH), at 58 percent compared to 41 percent in those without the condition. The trial also confirmed the frequent coexistence of metabolic syndrome and BPH, a fact that could be a consequence of the metabolic disorders associated with the disease itself, changes in sex hormones, and low levels of sex hormone-binding globulin (SHBG).
If you would like to learn more about the details of this study, you can do so via the following link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625953/
At ICUA, we specialize in benign prostatic hyperplasia (BPH). If you would like to learn about the different symptoms and possible treatments, please see the link below to this condition on our website:
https://www.icua.es/urologia-avanzada/hiperplasia/
ICUA Team
